BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 17650113)

  • 21. Activity requires soluble amyloid precursor protein alpha to promote neurite outgrowth in neural stem cell-derived neurons via activation of the MAPK pathway.
    Gakhar-Koppole N; Hundeshagen P; Mandl C; Weyer SW; Allinquant B; Müller U; Ciccolini F
    Eur J Neurosci; 2008 Sep; 28(5):871-82. PubMed ID: 18717733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Etazolate, a neuroprotective drug linking GABA(A) receptor pharmacology to amyloid precursor protein processing.
    Marcade M; Bourdin J; Loiseau N; Peillon H; Rayer A; Drouin D; Schweighoffer F; Désiré L
    J Neurochem; 2008 Jul; 106(1):392-404. PubMed ID: 18397369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitric oxide synthase inhibitors modulate nerve growth factor-mediated regulation of amyloid precursor protein expression in PC12 cells.
    Binnington JC; Kalisch BE
    J Neurochem; 2007 Apr; 101(2):422-33. PubMed ID: 17402971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matrix metalloproteinase-9 participates in NGF-induced α-secretase cleavage of amyloid-β protein precursor in PC12 cells.
    Fragkouli A; Tzinia AK; Charalampopoulos I; Gravanis A; Tsilibary EC
    J Alzheimers Dis; 2011; 24(4):705-19. PubMed ID: 21321391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD40/CD40L interaction induces Abeta production and increases gamma-secretase activity independently of tumor necrosis factor receptor associated factor (TRAF) signaling.
    Volmar CH; Ait-Ghezala G; Frieling J; Weeks OI; Mullan MJ
    Exp Cell Res; 2009 Aug; 315(13):2265-74. PubMed ID: 19422822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PI3-K- and PKC-dependent up-regulation of APP processing enzymes by retinoic acid.
    Holback S; Adlerz L; Gatsinzi T; Jacobsen KT; Iverfeldt K
    Biochem Biophys Res Commun; 2008 Jan; 365(2):298-303. PubMed ID: 17986385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of amyloid precursor protein reduces epsilon protein kinase C levels.
    Liron T; Seraya CB; Ish-Shalom M; Souroujon MC; Neumann D
    Neuroscience; 2007 Apr; 146(1):152-9. PubMed ID: 17321053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lactacystin decreases amyloid-beta peptide production by inhibiting beta-secretase activity.
    Kienlen-Campard P; Feyt C; Huysseune S; de Diesbach P; N'Kuli F; Courtoy PJ; Octave JN
    J Neurosci Res; 2006 Nov; 84(6):1311-22. PubMed ID: 16941495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bryostatin-1 vs. TPPB: dose-dependent APP processing and PKC-α, -δ, and -ε isoform activation in SH-SY5Y neuronal cells.
    Yi P; Schrott L; Castor TP; Alexander JS
    J Mol Neurosci; 2012 Sep; 48(1):234-44. PubMed ID: 22700373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of APP pathway mRNAs and proteins in Alzheimer's disease.
    Matsui T; Ingelsson M; Fukumoto H; Ramasamy K; Kowa H; Frosch MP; Irizarry MC; Hyman BT
    Brain Res; 2007 Aug; 1161():116-23. PubMed ID: 17586478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-secretase BACE1 is differentially controlled through muscarinic acetylcholine receptor signaling.
    Züchner T; Perez-Polo JR; Schliebs R
    J Neurosci Res; 2004 Jul; 77(2):250-7. PubMed ID: 15211591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of gamma-secretase activity reduces Abeta production, reduces oxidative stress, increases mitochondrial activity and leads to reduced vulnerability to apoptosis: Implications for the treatment of Alzheimer's disease.
    Sheng B; Gong K; Niu Y; Liu L; Yan Y; Lu G; Zhang L; Hu M; Zhao N; Zhang X; Tang P; Gong Y
    Free Radic Biol Med; 2009 May; 46(10):1362-75. PubMed ID: 19264123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endogenous beta-amyloid peptide synthesis modulates cAMP response element-regulated gene expression in PC12 cells.
    Echeverria V; Ducatenzeiler A; Chen CH; Cuello AC
    Neuroscience; 2005; 135(4):1193-202. PubMed ID: 16181736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the APP non-amyloidogenic signaling pathway and targeting alpha-secretase as an alternative drug target for treatment of Alzheimer's disease.
    Bandyopadhyay S; Goldstein LE; Lahiri DK; Rogers JT
    Curr Med Chem; 2007; 14(27):2848-64. PubMed ID: 18045131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of cellular beta-site of APP cleaving enzyme 1 activity and its modulation in neuronal assay systems.
    Volbracht C; Penzkofer S; Mansson D; Christensen KV; Fog K; Schildknecht S; Leist M; Nielsen J
    Anal Biochem; 2009 Apr; 387(2):208-20. PubMed ID: 19454261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of peptides derived from BACE1 catalytic domain on APP processing.
    Yeon SW; Jeon YJ; Hwang EM; Kim TY
    Peptides; 2007 Apr; 28(4):838-44. PubMed ID: 17293005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Arctic Alzheimer mutation favors intracellular amyloid-beta production by making amyloid precursor protein less available to alpha-secretase.
    Sahlin C; Lord A; Magnusson K; Englund H; Almeida CG; Greengard P; Nyberg F; Gouras GK; Lannfelt L; Nilsson LN
    J Neurochem; 2007 May; 101(3):854-62. PubMed ID: 17448150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
    Martone RL; Zhou H; Atchison K; Comery T; Xu JZ; Huang X; Gong X; Jin M; Kreft A; Harrison B; Mayer SC; Aschmies S; Gonzales C; Zaleska MM; Riddell DR; Wagner E; Lu P; Sun SC; Sonnenberg-Reines J; Oganesian A; Adkins K; Leach MW; Clarke DW; Huryn D; Abou-Gharbia M; Magolda R; Bard J; Frick G; Raje S; Forlow SB; Balliet C; Burczynski ME; Reinhart PH; Wan HI; Pangalos MN; Jacobsen JS
    J Pharmacol Exp Ther; 2009 Nov; 331(2):598-608. PubMed ID: 19671883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracellular copper deficiency increases amyloid-beta secretion by diverse mechanisms.
    Cater MA; McInnes KT; Li QX; Volitakis I; La Fontaine S; Mercer JF; Bush AI
    Biochem J; 2008 May; 412(1):141-52. PubMed ID: 18248325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a biological candidate marker of Alzheimer's disease.
    Hampel H; Shen Y
    Scand J Clin Lab Invest; 2009; 69(1):8-12. PubMed ID: 18609117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.